The IgM isotype of anti-annexin A5 antibodies and multiple positivity of conventional antiphospholipid antibodies: increasing the number of clinical manifestations of primary antiphospholipid syndrome

Clinical Rheumatology

Volumn 35, Issue 5, 2016, Pages 1361-1365

  Bećarević, Mirjana ^a,b   Stojanović, Ljudmila ^c   Ignjatović, Svetlana ^b,c   Dopsaj, Violeta ^b,c  

^a UNIVERSITY OF NOVI SAD   (Serbia)

^b CLINICAL CENTER OF SERBIA   (Serbia)

^c UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Anti annexin A5 antibodies; Anti 2gpI antibodies; Anticardiolipin antibodies; IgG and IgM isotypes; Lupus anticoagulant; Primary antiphospholipid syndrome

Indexed keywords

ANNEXIN A5 ANTIBODY; ANTIBODY; BETA2 GLYCOPROTEIN 1 ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; PHOSPHOLIPID ANTIBODY; UNCLASSIFIED DRUG; AUTOANTIBODY; IMMUNOGLOBULIN M; LIPOCORTIN 5;

ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CLINICAL FEATURE; DISEASE DURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECURRENT ABORTION; SYMPTOM; VEIN THROMBOSIS; IMMUNOLOGY; MIDDLE AGED;

ADULT; ANNEXIN A5; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; AUTOANTIBODIES; FEMALE; HUMANS; IMMUNOGLOBULIN M; MALE; MIDDLE AGED;

EID: 84961113070     PISSN: 07703198     EISSN: 14349949     Source Type: Journal    
DOI: 10.1007/s10067-016-3230-0     Document Type: Article

References (20)

1. van den Hoogen LL, van Roon JAG, Radstake TRDJ, Fritsch-Stork RDE, Derksen RHWM (2015) Delineating the deranged immune system in the antiphospholipid syndrome. Autoimmun Rev. doi:10.1016/j.autrev.2015.08.011
2. Bertolaccini ML, Amengual O, Andreoli L, Atsumi T, Chighizola CB, Forastiero R et al (2014) 14th International Congress on Antiphospholipid Antibodies Task Force. Report on antiphospholipid syndrome laboratory diagnostics and trends. Autoimmun Rev 13:917–930
3. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R et al (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome. J Thromb Haemost 4:295–306
4. Pengo V, Banzato A, Denas G et al (2013) Correct laboratory approach to APS diagnosis and monitoring. Autoimmun Rev 12:832–834
5. Forastiero R (2014) Multiple antiphospholipid antibodies positivity and antiphospholipid syndrome criteria re-evaluation. Lupus 23(12):1252–4
6. Hernández-Molina G, Espericueta-Arriola G, Cabral AR (2013) The role of lupus anticoagulant and triple marker positivity as risk factors for rethrombosis in patients with primary antiphospholipid syndrome. Clin Exp Rheumatol 31(3):382–8
7. Nayfe R, Uthman I, Aoun J, Aldin ES, Merashil M, Khamashta MA (2013) Seronegative antiphospholipid syndrome. Rheumatology 52:1358–1367
8. de Laat B, Wu XX, van Lummel M, Derksen RHWM, de Groot PG, Rand JH (2007) Correlation between antiphospholipid antibodies that recognize domain I of beta2-glycoprotein I and a reduction in the anticoagulant activity of annexin A5. Blood 109:1490–4
9. Brandt JT, Triplett DA, Alving B, Scharrer J (1995) Criteria for the diagnosis of lupus anticoagulants: an update on behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipd Antibody of the Scientific and Standardisation Committee of the International Society of Thrombosis and Haemostasis. Thromb Haemost 74(4):1185–90
10. Galli M, Luciani D, Bertolini G, Barbui T (2003) Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature. Blood 101(5):1827–32
11. Forastiero R, Martinuzzo M, Pombo G, Puente D, Rossi A, Celebrin L et al (2005) A prospective study of antibodies to beta2-glycoprotein I and prothrombin, and a risk of thrombosis. J Thromb Haemost 3(6):1231–8
12. Del Ross T, Ruffatti A, Cuffaro S, Tonello M, Calliagaro A, Favaro M et al (2015) The clinical relevance of the IgM isotype of antiphospholipid antibodies in the vascular antiphospholipid syndrome. Thromb Res. doi:10.1016/j.thromres.2015.08.019
13. Nasef A, Ibrahim M, Riad N, Mousa S (2014) Plasma annexin A5, anti-annexin A5 antibodies and annexin A5 polymorphism in Egyptian female patients with systemic lupus erythematosus and antiphospholipid syndrome. Clin Lab 60(1):133–7
14. Gris JC, Bouvier S (2013) Antiphospholipid syndrome: looking for a refocusing. Thromb Res 131(1):S28–S31
15. De Laat B, Derksen RHWM, Mackie IJ et al (2006) Annexin A5 polimorphism (−1C > T) and the presence of anti-annexin A5 antibodies in the antiphospholipid syndrome. Ann Rheum Dis 65(11):1468–72
16. Amaral M, Favas C, Delgado Alves J (2010) Persistency of low levels of anticardiolipin and anti-beta2 glycoprotein 1 in thrombosis. Eur J Intern Med 21:101–103
17. Mekinian A, Loire-Berson P, Nicaise-Roland P, Lachassinne E, Stirnrmann J, Boffa MC et al (2012) Outcomes and treatment of obstetrical antiphospholipid syndrome in women with low antiphospholipid antibody levels. J Reprod Immunol 94:222–226
18. Boffa MC, Boinot C, De Carolis S, Rovere-Querini P, Aurousseau MH, Allegri F et al (2009) Laboratory criteria of the obstetrical antiphospholipid syndrome. Data from a multicentric prospective European women cohort. Thromb Haemost 102:25–28
19. Pengo V (2011) Antiphospholipid syndrome: interpretation of laboratory data. J Thromb Haemost 9(2):402–3
20. Kist WJ, Janssen NG, Kalk JJ, Hague WM, Dekker GA, de Vries JL (2008) Thrombophilias and adverse pregnancy outcome—a confounded problem. Thromb Haemost 99:77–85